nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—skin cancer—head and neck cancer	0.725	1	CtDrD
Vismodegib—ABCG2—Fluorouracil—head and neck cancer	0.0426	0.231	CbGbCtD
Vismodegib—ABCG2—Docetaxel—head and neck cancer	0.0325	0.176	CbGbCtD
Vismodegib—ALB—Fluorouracil—head and neck cancer	0.0294	0.159	CbGbCtD
Vismodegib—CYP2C8—Fluorouracil—head and neck cancer	0.0227	0.123	CbGbCtD
Vismodegib—CYP2C9—Fluorouracil—head and neck cancer	0.0158	0.0858	CbGbCtD
Vismodegib—ABCB1—Vinblastine—head and neck cancer	0.0142	0.0771	CbGbCtD
Vismodegib—SHH—secondary palate—head and neck cancer	0.014	0.263	CbGeAlD
Vismodegib—SHH—jaw skeleton—head and neck cancer	0.0127	0.238	CbGeAlD
Vismodegib—ABCB1—Docetaxel—head and neck cancer	0.0117	0.0636	CbGbCtD
Vismodegib—CYP3A4—Vinblastine—head and neck cancer	0.00853	0.0462	CbGbCtD
Vismodegib—SHH—skull—head and neck cancer	0.00785	0.148	CbGeAlD
Vismodegib—CYP3A4—Docetaxel—head and neck cancer	0.00703	0.0381	CbGbCtD
Vismodegib—SHH—hair follicle—head and neck cancer	0.00346	0.0652	CbGeAlD
Vismodegib—ORM1—saliva—head and neck cancer	0.0022	0.0414	CbGeAlD
Vismodegib—SHH—connective tissue—head and neck cancer	0.00166	0.0314	CbGeAlD
Vismodegib—SHH—epithelium—head and neck cancer	0.00158	0.0298	CbGeAlD
Vismodegib—SMO—parotid gland—head and neck cancer	0.00132	0.0249	CbGeAlD
Vismodegib—SMO—saliva-secreting gland—head and neck cancer	0.00127	0.0239	CbGeAlD
Vismodegib—SMO—connective tissue—head and neck cancer	0.00116	0.0219	CbGeAlD
Vismodegib—SHH—head—head and neck cancer	0.000981	0.0185	CbGeAlD
Vismodegib—SMO—trachea—head and neck cancer	0.000977	0.0184	CbGeAlD
Vismodegib—SMO—thyroid gland—head and neck cancer	0.000773	0.0146	CbGeAlD
Vismodegib—SMO—head—head and neck cancer	0.000686	0.0129	CbGeAlD
Vismodegib—Etoricoxib—PTGS2—head and neck cancer	0.000652	0.629	CrCbGaD
Vismodegib—Amenorrhoea—Hydroxyurea—head and neck cancer	0.000494	0.0477	CcSEcCtD
Vismodegib—SMO—lymph node—head and neck cancer	0.00048	0.00905	CbGeAlD
Vismodegib—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.000458	0.0443	CcSEcCtD
Vismodegib—Blood urea increased—Hydroxyurea—head and neck cancer	0.000409	0.0396	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—head and neck cancer	0.000385	0.371	CrCbGaD
Vismodegib—ABCG2—parotid gland—head and neck cancer	0.000346	0.00653	CbGeAlD
Vismodegib—ABCG2—saliva-secreting gland—head and neck cancer	0.000332	0.00625	CbGeAlD
Vismodegib—Breast disorder—Hydroxyurea—head and neck cancer	0.000284	0.0275	CcSEcCtD
Vismodegib—Ageusia—Docetaxel—head and neck cancer	0.000278	0.0269	CcSEcCtD
Vismodegib—Amenorrhoea—Docetaxel—head and neck cancer	0.000256	0.0248	CcSEcCtD
Vismodegib—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.000225	0.0218	CcSEcCtD
Vismodegib—Alopecia—Vinblastine—head and neck cancer	0.000211	0.0204	CcSEcCtD
Vismodegib—ORM1—lymph node—head and neck cancer	0.00021	0.00396	CbGeAlD
Vismodegib—ABCG2—thyroid gland—head and neck cancer	0.000202	0.00382	CbGeAlD
Vismodegib—Alopecia—Hydroxyurea—head and neck cancer	0.000192	0.0186	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000188	0.0182	CcSEcCtD
Vismodegib—ALB—lymph node—head and neck cancer	0.000184	0.00347	CbGeAlD
Vismodegib—Hyponatraemia—Docetaxel—head and neck cancer	0.000164	0.0159	CcSEcCtD
Vismodegib—Pain in extremity—Docetaxel—head and neck cancer	0.000164	0.0158	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00016	0.0155	CcSEcCtD
Vismodegib—Dehydration—Docetaxel—head and neck cancer	0.000152	0.0147	CcSEcCtD
Vismodegib—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000152	0.0147	CcSEcCtD
Vismodegib—Skin disorder—Hydroxyurea—head and neck cancer	0.00015	0.0145	CcSEcCtD
Vismodegib—Abdominal pain upper—Docetaxel—head and neck cancer	0.000149	0.0144	CcSEcCtD
Vismodegib—Breast disorder—Docetaxel—head and neck cancer	0.000148	0.0143	CcSEcCtD
Vismodegib—Decreased appetite—Vinblastine—head and neck cancer	0.000147	0.0142	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000147	0.0142	CcSEcCtD
Vismodegib—Constipation—Vinblastine—head and neck cancer	0.000145	0.014	CcSEcCtD
Vismodegib—Pain—Vinblastine—head and neck cancer	0.000145	0.014	CcSEcCtD
Vismodegib—ABCB1—epithelium—head and neck cancer	0.000143	0.00269	CbGeAlD
Vismodegib—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000139	0.0134	CcSEcCtD
Vismodegib—Alopecia—Fluorouracil—head and neck cancer	0.000139	0.0134	CcSEcCtD
Vismodegib—Dyspepsia—Hydroxyurea—head and neck cancer	0.000136	0.0132	CcSEcCtD
Vismodegib—Decreased appetite—Hydroxyurea—head and neck cancer	0.000134	0.013	CcSEcCtD
Vismodegib—Abdominal pain—Vinblastine—head and neck cancer	0.000134	0.013	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000134	0.0129	CcSEcCtD
Vismodegib—Fatigue—Hydroxyurea—head and neck cancer	0.000133	0.0129	CcSEcCtD
Vismodegib—Pain—Hydroxyurea—head and neck cancer	0.000132	0.0128	CcSEcCtD
Vismodegib—Constipation—Hydroxyurea—head and neck cancer	0.000132	0.0128	CcSEcCtD
Vismodegib—Weight decreased—Docetaxel—head and neck cancer	0.000128	0.0124	CcSEcCtD
Vismodegib—ABCB1—trachea—head and neck cancer	0.000126	0.00238	CbGeAlD
Vismodegib—ABCG2—lymph node—head and neck cancer	0.000126	0.00237	CbGeAlD
Vismodegib—Asthenia—Vinblastine—head and neck cancer	0.000122	0.0118	CcSEcCtD
Vismodegib—Myalgia—Fluorouracil—head and neck cancer	0.000116	0.0112	CcSEcCtD
Vismodegib—Diarrhoea—Vinblastine—head and neck cancer	0.000116	0.0112	CcSEcCtD
Vismodegib—Connective tissue disorder—Docetaxel—head and neck cancer	0.000111	0.0107	CcSEcCtD
Vismodegib—Asthenia—Hydroxyurea—head and neck cancer	0.000111	0.0107	CcSEcCtD
Vismodegib—ABCB1—lymphoid tissue—head and neck cancer	0.00011	0.00207	CbGeAlD
Vismodegib—Nervous system disorder—Fluorouracil—head and neck cancer	0.000109	0.0106	CcSEcCtD
Vismodegib—Vomiting—Vinblastine—head and neck cancer	0.000108	0.0104	CcSEcCtD
Vismodegib—Diarrhoea—Hydroxyurea—head and neck cancer	0.000106	0.0102	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000101	0.0098	CcSEcCtD
Vismodegib—Nausea—Vinblastine—head and neck cancer	0.000101	0.00974	CcSEcCtD
Vismodegib—Alopecia—Docetaxel—head and neck cancer	0.0001	0.00966	CcSEcCtD
Vismodegib—ABCB1—thyroid gland—head and neck cancer	9.98e-05	0.00188	CbGeAlD
Vismodegib—Malnutrition—Docetaxel—head and neck cancer	9.85e-05	0.00952	CcSEcCtD
Vismodegib—Vomiting—Hydroxyurea—head and neck cancer	9.84e-05	0.0095	CcSEcCtD
Vismodegib—Dyspepsia—Fluorouracil—head and neck cancer	9.8e-05	0.00947	CcSEcCtD
Vismodegib—Rash—Hydroxyurea—head and neck cancer	9.76e-05	0.00943	CcSEcCtD
Vismodegib—Dermatitis—Hydroxyurea—head and neck cancer	9.75e-05	0.00942	CcSEcCtD
Vismodegib—Decreased appetite—Fluorouracil—head and neck cancer	9.68e-05	0.00935	CcSEcCtD
Vismodegib—Dysgeusia—Docetaxel—head and neck cancer	9.64e-05	0.00932	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Fluorouracil—head and neck cancer	9.61e-05	0.00929	CcSEcCtD
Vismodegib—Back pain—Docetaxel—head and neck cancer	9.53e-05	0.0092	CcSEcCtD
Vismodegib—Pain—Fluorouracil—head and neck cancer	9.52e-05	0.0092	CcSEcCtD
Vismodegib—Muscle spasms—Docetaxel—head and neck cancer	9.47e-05	0.00915	CcSEcCtD
Vismodegib—Nausea—Hydroxyurea—head and neck cancer	9.19e-05	0.00888	CcSEcCtD
Vismodegib—ABCB1—head—head and neck cancer	8.86e-05	0.00167	CbGeAlD
Vismodegib—Arthralgia—Docetaxel—head and neck cancer	8.38e-05	0.0081	CcSEcCtD
Vismodegib—Myalgia—Docetaxel—head and neck cancer	8.38e-05	0.0081	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	8.33e-05	0.00805	CcSEcCtD
Vismodegib—Nervous system disorder—Docetaxel—head and neck cancer	7.88e-05	0.00762	CcSEcCtD
Vismodegib—Pruritus—Fluorouracil—head and neck cancer	7.88e-05	0.00761	CcSEcCtD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	7.87e-05	0.00305	CbGpPWpGaD
Vismodegib—Skin disorder—Docetaxel—head and neck cancer	7.81e-05	0.00754	CcSEcCtD
Vismodegib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.81e-05	0.00303	CbGpPWpGaD
Vismodegib—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.7e-05	0.00299	CbGpPWpGaD
Vismodegib—Diarrhoea—Fluorouracil—head and neck cancer	7.62e-05	0.00736	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—GRP—head and neck cancer	7.54e-05	0.00293	CbGpPWpGaD
Vismodegib—Musculoskeletal discomfort—Docetaxel—head and neck cancer	7.32e-05	0.00708	CcSEcCtD
Vismodegib—SHH—Signaling Pathways—STAT6—head and neck cancer	7.32e-05	0.00284	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—NAT2—head and neck cancer	7.18e-05	0.00279	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—GRP—head and neck cancer	7.15e-05	0.00277	CbGpPWpGaD
Vismodegib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.12e-05	0.00276	CbGpPWpGaD
Vismodegib—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.09e-05	0.00275	CbGpPWpGaD
Vismodegib—Vomiting—Fluorouracil—head and neck cancer	7.08e-05	0.00684	CcSEcCtD
Vismodegib—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	7.08e-05	0.00275	CbGpPWpGaD
Vismodegib—Dyspepsia—Docetaxel—head and neck cancer	7.08e-05	0.00684	CcSEcCtD
Vismodegib—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.02e-05	0.00273	CbGpPWpGaD
Vismodegib—Rash—Fluorouracil—head and neck cancer	7.02e-05	0.00678	CcSEcCtD
Vismodegib—Dermatitis—Fluorouracil—head and neck cancer	7.02e-05	0.00678	CcSEcCtD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.01e-05	0.00272	CbGpPWpGaD
Vismodegib—Decreased appetite—Docetaxel—head and neck cancer	6.99e-05	0.00675	CcSEcCtD
Vismodegib—SMO—Signaling Pathways—STAT6—head and neck cancer	6.94e-05	0.00269	CbGpPWpGaD
Vismodegib—Gastrointestinal disorder—Docetaxel—head and neck cancer	6.94e-05	0.0067	CcSEcCtD
Vismodegib—Fatigue—Docetaxel—head and neck cancer	6.93e-05	0.0067	CcSEcCtD
Vismodegib—Constipation—Docetaxel—head and neck cancer	6.87e-05	0.00664	CcSEcCtD
Vismodegib—Pain—Docetaxel—head and neck cancer	6.87e-05	0.00664	CcSEcCtD
Vismodegib—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	6.78e-05	0.00263	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	6.64e-05	0.00258	CbGpPWpGaD
Vismodegib—Nausea—Fluorouracil—head and neck cancer	6.62e-05	0.00639	CcSEcCtD
Vismodegib—Gastrointestinal pain—Docetaxel—head and neck cancer	6.57e-05	0.00635	CcSEcCtD
Vismodegib—CYP2C9—Biological oxidations—NAT2—head and neck cancer	6.55e-05	0.00254	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—YAP1—head and neck cancer	6.48e-05	0.00251	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	6.47e-05	0.00251	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	6.46e-05	0.00251	CbGpPWpGaD
Vismodegib—Abdominal pain—Docetaxel—head and neck cancer	6.35e-05	0.00614	CcSEcCtD
Vismodegib—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.33e-05	0.00246	CbGpPWpGaD
Vismodegib—ABCB1—lymph node—head and neck cancer	6.2e-05	0.00117	CbGeAlD
Vismodegib—SMO—Signaling Pathways—YAP1—head and neck cancer	6.14e-05	0.00238	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	6.12e-05	0.00237	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.02e-05	0.00233	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	5.99e-05	0.00232	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	5.89e-05	0.00229	CbGpPWpGaD
Vismodegib—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	5.81e-05	0.00225	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.77e-05	0.00224	CbGpPWpGaD
Vismodegib—Asthenia—Docetaxel—head and neck cancer	5.77e-05	0.00557	CcSEcCtD
Vismodegib—Pruritus—Docetaxel—head and neck cancer	5.69e-05	0.00549	CcSEcCtD
Vismodegib—Diarrhoea—Docetaxel—head and neck cancer	5.5e-05	0.00531	CcSEcCtD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	5.37e-05	0.00208	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	5.36e-05	0.00208	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—UROD—head and neck cancer	5.34e-05	0.00207	CbGpPWpGaD
Vismodegib—Vomiting—Docetaxel—head and neck cancer	5.11e-05	0.00494	CcSEcCtD
Vismodegib—Rash—Docetaxel—head and neck cancer	5.07e-05	0.0049	CcSEcCtD
Vismodegib—Dermatitis—Docetaxel—head and neck cancer	5.06e-05	0.00489	CcSEcCtD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.9e-05	0.0019	CbGpPWpGaD
Vismodegib—Nausea—Docetaxel—head and neck cancer	4.77e-05	0.00461	CcSEcCtD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.69e-05	0.00182	CbGpPWpGaD
Vismodegib—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.63e-05	0.0018	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—CASP8—head and neck cancer	4.46e-05	0.00173	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—IL2—head and neck cancer	4.44e-05	0.00172	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—NAT2—head and neck cancer	4.32e-05	0.00168	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	4.26e-05	0.00165	CbGpPWpGaD
Vismodegib—SHH—Disease—NOTCH1—head and neck cancer	4.17e-05	0.00162	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	3.97e-05	0.00154	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	3.92e-05	0.00152	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.9e-05	0.00151	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	3.81e-05	0.00148	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.81e-05	0.00148	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	3.77e-05	0.00146	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	3.71e-05	0.00144	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.69e-05	0.00143	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	3.55e-05	0.00138	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	3.5e-05	0.00136	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—IL2—head and neck cancer	3.4e-05	0.00132	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL2—head and neck cancer	3.37e-05	0.00131	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	3.36e-05	0.0013	CbGpPWpGaD
Vismodegib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	3.33e-05	0.00129	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	3.32e-05	0.00129	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—UROD—head and neck cancer	3.31e-05	0.00129	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	3.31e-05	0.00128	CbGpPWpGaD
Vismodegib—ALB—Metabolism—UROD—head and neck cancer	3.29e-05	0.00128	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.24e-05	0.00126	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VEGFA—head and neck cancer	3.24e-05	0.00126	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	3.23e-05	0.00125	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—IL2—head and neck cancer	3.23e-05	0.00125	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	3.22e-05	0.00125	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.19e-05	0.00124	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—head and neck cancer	3.1e-05	0.0012	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	3.08e-05	0.0012	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	3.06e-05	0.00119	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	3.02e-05	0.00117	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—UROD—head and neck cancer	2.96e-05	0.00115	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NOTCH1—head and neck cancer	2.92e-05	0.00113	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—UROD—head and neck cancer	2.89e-05	0.00112	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	2.86e-05	0.00111	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—head and neck cancer	2.85e-05	0.00111	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NOTCH1—head and neck cancer	2.77e-05	0.00107	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—MAPK3—head and neck cancer	2.74e-05	0.00106	CbGpPWpGaD
Vismodegib—SHH—Disease—PTEN—head and neck cancer	2.7e-05	0.00105	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—UROD—head and neck cancer	2.7e-05	0.00105	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—MAPK1—head and neck cancer	2.6e-05	0.00101	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EGFR—head and neck cancer	2.6e-05	0.00101	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—MAPK3—head and neck cancer	2.59e-05	0.00101	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.57e-05	0.000997	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.56e-05	0.000992	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—MAPK1—head and neck cancer	2.47e-05	0.000957	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EGFR—head and neck cancer	2.47e-05	0.000957	CbGpPWpGaD
Vismodegib—SHH—Disease—STAT3—head and neck cancer	2.42e-05	0.000937	CbGpPWpGaD
Vismodegib—SHH—Disease—MAPK3—head and neck cancer	2.31e-05	0.000895	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.29e-05	0.00089	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—PIK3CA—head and neck cancer	2.26e-05	0.000876	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NAT2—head and neck cancer	2.22e-05	0.00086	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	2.2e-05	0.000854	CbGpPWpGaD
Vismodegib—SHH—Disease—MAPK1—head and neck cancer	2.2e-05	0.000852	CbGpPWpGaD
Vismodegib—SHH—Disease—EGFR—head and neck cancer	2.19e-05	0.000852	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—PIK3CA—head and neck cancer	2.14e-05	0.000831	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	2.13e-05	0.000827	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	2.11e-05	0.000819	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	2.1e-05	0.000816	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.09e-05	0.000812	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—HRAS—head and neck cancer	2.09e-05	0.000811	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.02e-05	0.000784	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IL2—head and neck cancer	2.01e-05	0.00078	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.99e-05	0.000774	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—HRAS—head and neck cancer	1.98e-05	0.000769	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CCND1—head and neck cancer	1.96e-05	0.00076	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—DPYD—head and neck cancer	1.94e-05	0.000754	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IL2—head and neck cancer	1.91e-05	0.000739	CbGpPWpGaD
Vismodegib—SHH—Disease—PIK3CA—head and neck cancer	1.91e-05	0.000739	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PTEN—head and neck cancer	1.89e-05	0.000734	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.89e-05	0.000733	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CCND1—head and neck cancer	1.86e-05	0.000721	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AKT1—head and neck cancer	1.84e-05	0.000716	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—YAP1—head and neck cancer	1.84e-05	0.000716	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.79e-05	0.000696	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PTEN—head and neck cancer	1.79e-05	0.000696	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—UROD—head and neck cancer	1.78e-05	0.00069	CbGpPWpGaD
Vismodegib—SHH—Disease—HRAS—head and neck cancer	1.76e-05	0.000684	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AKT1—head and neck cancer	1.75e-05	0.000679	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—head and neck cancer	1.71e-05	0.000663	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—STAT3—head and neck cancer	1.69e-05	0.000656	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	1.69e-05	0.000655	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.62e-05	0.000629	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—head and neck cancer	1.62e-05	0.000628	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK3—head and neck cancer	1.62e-05	0.000627	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—STAT3—head and neck cancer	1.6e-05	0.000622	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.56e-05	0.000607	CbGpPWpGaD
Vismodegib—SHH—Disease—AKT1—head and neck cancer	1.56e-05	0.000604	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MAPK1—head and neck cancer	1.54e-05	0.000597	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EGFR—head and neck cancer	1.54e-05	0.000596	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK3—head and neck cancer	1.53e-05	0.000594	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.46e-05	0.000567	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MAPK1—head and neck cancer	1.46e-05	0.000566	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EGFR—head and neck cancer	1.46e-05	0.000565	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.45e-05	0.000564	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.45e-05	0.000561	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.44e-05	0.000558	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	1.44e-05	0.000557	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.41e-05	0.000548	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NAT2—head and neck cancer	1.38e-05	0.000534	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NAT2—head and neck cancer	1.37e-05	0.000531	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	1.36e-05	0.000527	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.34e-05	0.000519	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PIK3CA—head and neck cancer	1.33e-05	0.000518	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.3e-05	0.000506	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.29e-05	0.000501	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.29e-05	0.000501	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—head and neck cancer	1.29e-05	0.000501	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.27e-05	0.000494	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.27e-05	0.000494	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PIK3CA—head and neck cancer	1.26e-05	0.000491	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—HRAS—head and neck cancer	1.23e-05	0.000479	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NAT2—head and neck cancer	1.23e-05	0.000476	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—head and neck cancer	1.22e-05	0.000475	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—DPYD—head and neck cancer	1.21e-05	0.000468	CbGpPWpGaD
Vismodegib—ALB—Metabolism—DPYD—head and neck cancer	1.2e-05	0.000465	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NAT2—head and neck cancer	1.2e-05	0.000465	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.19e-05	0.000461	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.18e-05	0.000457	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—HRAS—head and neck cancer	1.17e-05	0.000454	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—YAP1—head and neck cancer	1.14e-05	0.000444	CbGpPWpGaD
Vismodegib—ALB—Metabolism—YAP1—head and neck cancer	1.14e-05	0.000442	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.12e-05	0.000435	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NAT2—head and neck cancer	1.12e-05	0.000434	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TYMS—head and neck cancer	1.11e-05	0.00043	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.1e-05	0.000428	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—head and neck cancer	1.09e-05	0.000425	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AKT1—head and neck cancer	1.09e-05	0.000423	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—DPYD—head and neck cancer	1.08e-05	0.000418	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.07e-05	0.000414	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—DPYD—head and neck cancer	1.05e-05	0.000408	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GPX1—head and neck cancer	1.05e-05	0.000407	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.04e-05	0.000403	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AKT1—head and neck cancer	1.03e-05	0.000401	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—YAP1—head and neck cancer	1.02e-05	0.000396	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—YAP1—head and neck cancer	9.97e-06	0.000387	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—DPYD—head and neck cancer	9.82e-06	0.000381	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—YAP1—head and neck cancer	9.32e-06	0.000361	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	9.16e-06	0.000355	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	9.02e-06	0.00035	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IL2—head and neck cancer	8.71e-06	0.000338	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.6e-06	0.000334	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.55e-06	0.000332	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.68e-06	0.000298	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.5e-06	0.000291	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.46e-06	0.000289	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—head and neck cancer	7.4e-06	0.000287	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NAT2—head and neck cancer	7.38e-06	0.000286	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7e-06	0.000272	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK3—head and neck cancer	7e-06	0.000272	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TYMS—head and neck cancer	6.87e-06	0.000267	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TYMS—head and neck cancer	6.83e-06	0.000265	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—head and neck cancer	6.79e-06	0.000264	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—head and neck cancer	6.75e-06	0.000262	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.69e-06	0.00026	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MAPK1—head and neck cancer	6.66e-06	0.000258	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GPX1—head and neck cancer	6.51e-06	0.000252	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—DPYD—head and neck cancer	6.47e-06	0.000251	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GPX1—head and neck cancer	6.47e-06	0.000251	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1A1—head and neck cancer	6.44e-06	0.00025	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1A1—head and neck cancer	6.4e-06	0.000248	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—head and neck cancer	6.17e-06	0.000239	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—YAP1—head and neck cancer	6.14e-06	0.000238	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TYMS—head and neck cancer	6.13e-06	0.000238	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.1e-06	0.000237	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—head and neck cancer	6.06e-06	0.000235	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TYMS—head and neck cancer	5.99e-06	0.000232	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—head and neck cancer	5.92e-06	0.00023	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GPX1—head and neck cancer	5.81e-06	0.000225	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—PIK3CA—head and neck cancer	5.78e-06	0.000224	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.75e-06	0.000223	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GPX1—head and neck cancer	5.67e-06	0.00022	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.61e-06	0.000218	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TYMS—head and neck cancer	5.59e-06	0.000217	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—head and neck cancer	5.59e-06	0.000217	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.53e-06	0.000215	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTEN—head and neck cancer	5.38e-06	0.000209	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—HRAS—head and neck cancer	5.35e-06	0.000207	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GPX1—head and neck cancer	5.29e-06	0.000205	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.29e-06	0.000205	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.26e-06	0.000204	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.24e-06	0.000203	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.72e-06	0.000183	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—AKT1—head and neck cancer	4.72e-06	0.000183	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.31e-06	0.000167	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—head and neck cancer	3.83e-06	0.000149	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—head and neck cancer	3.81e-06	0.000148	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3CA—head and neck cancer	3.8e-06	0.000147	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TYMS—head and neck cancer	3.69e-06	0.000143	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.65e-06	0.000141	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GPX1—head and neck cancer	3.49e-06	0.000136	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.46e-06	0.000134	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.42e-06	0.000133	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTEN—head and neck cancer	3.34e-06	0.00013	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—head and neck cancer	3.34e-06	0.000129	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTEN—head and neck cancer	3.32e-06	0.000129	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.12e-06	0.000121	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—AKT1—head and neck cancer	3.1e-06	0.00012	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTEN—head and neck cancer	2.98e-06	0.000116	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTEN—head and neck cancer	2.91e-06	0.000113	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTEN—head and neck cancer	2.72e-06	0.000105	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.36e-06	9.14e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3CA—head and neck cancer	2.34e-06	9.09e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.1e-06	8.16e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.06e-06	7.98e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.05e-06	7.97e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—AKT1—head and neck cancer	1.92e-06	7.47e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.92e-06	7.44e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—AKT1—head and neck cancer	1.91e-06	7.43e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTEN—head and neck cancer	1.79e-06	6.96e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—AKT1—head and neck cancer	1.72e-06	6.67e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—AKT1—head and neck cancer	1.68e-06	6.51e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—AKT1—head and neck cancer	1.57e-06	6.08e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.26e-06	4.91e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—AKT1—head and neck cancer	1.03e-06	4.01e-05	CbGpPWpGaD
